黑料网

Women’s Mood Disorders Program Endowment Fund (349323):

The 黑料网 Center for Women鈥檚 Mood Disorders is advancing the mission of excellence in clinical care, research, and training the next generation of clinicians and researchers. This fund supports our mission by providing training opportunities for clinicians and scientists, enhancing community engagement, and improving clinical care for patients across North Carolina now and for generations to come.

Women’s Mood Disorders Research Fund (346017):

Our Center is a national leader in advancing the understanding of Women鈥檚 Mood Disorders and have generated multiple high-profile publications on the causes of and treatments for Perimenopausal Depression, Premenstrual Dysphoric Disorder, and Perinatal Depression. We have the country鈥檚 only NIH training fellowship in Reproductive Psychiatry (NIH T32 grant). We have the country鈥檚 first Inpatient Perinatal Psychiatric Unit, and we performed the first study of, and were the lead site for the neurosteroid brexanolone (Zulresso), the first and only FDA approved medication specifically for Postpartum Depression. Our researchers have served as leaders of national organizations at the forefront of clinical neuroscience, including the Marce Society, the Society of Biological Psychiatry, and the American College of Neuropsychopharmacology.

This fund supports our research mission by supporting innovative research aimed at identifying the causes and best treatments for reproductive-related mood disorders; allowing junior scientists to present their research at scientific meetings; training junior researchers; promoting collaboration among clinicians, scientists, and the communities they serve; and ensuring infrastructure to support high-quality research focused on women鈥檚 mental health.